CmaxInsight's Competitive Intelligence put together random bits and
pieces of data and transform into strategic knowledge to support pharma and life-science
companies in addressing specific Key Intelligence Questions (KIQ's).
Our competitive intelligence gives your organization the competitive edge, arming
you the strategic intelligence which puts you ahead of the market curve, and enabling you
to realize your organization’s potential and move towards your unique vision.
Continuous tracking of clinical, regulatory & commercial news along with clinical trial and clinical evidence across a range of disease areas. Insight is focused on our clients’ own intelligence priorities and analyses the implications for their competitive positioning
In-depth analysis of competitor pipelines by Phase/MOA/end points/study populations etc. which enables you to identify the key competition and their strategy well in advance
Comprehensive picture of marketed and pipeline drugs landscape along with the likelihood of approval for pipeline drugs and lifecycle management activity for marketed drugs
Keep a track on market leader and emerging player along with their product which help to understand the competitive environment around the therapy area
Assessment of competitive clinical trial designs, endpoints, treatment settings, study populations for head-to-head comparison of likely marketing claims and target product profiles
Comprehensive information and access to all deals and agreement which helps to understand trend, progression of assets, deal term, deal value and its rationale
Conference Intelligence that goes beyond traditional outputs to look at “strategic intent” of companies